Neogenomics Laboratories, Inc.

Neogenomics Laboratories, Inc., headquartered in Fort Myers, Florida, is a for-profit cancer diagnostics laboratory that provides specialized reference laboratory testing services to the federal government exclusively as a prime contractor on full-and-open competition awards with no set-aside participation. The vendor competes across 114 federal prime awards spanning specialized diagnostic testing, molecular pathology, genetic sequencing, immunohistochemistry, flow cytometry, fluorescence in situ hybridization (FISH), and anatomic pathology analysis to support veteran, Native American, and civilian federal healthcare programs.

Neogenomics' federal customer base concentrates heavily within the Veterans Health Administration and the Indian Health Service. The top five customers account for 82% of combined potential value: the Department of Veterans Affairs Veterans Integrated Service Network 17 (10 awards, $23.7 million), Veterans Integrated Service Network 21 (10 awards, $13.8 million), Veterans Integrated Service Network 1 (13 awards, $7.3 million), the Indian Health Service (16 awards, $6.5 million), and Veterans Integrated Service Network 4 (8 awards, $6.1 million). Neogenomics also maintains a smaller customer set at the National Heart Lung and Blood Institute (11 awards, $2 million) and the Defense Health Agency, including a $445,942 definitive contract with the 60th Medical Group at David Grant Medical Center, Travis Air Force Base, running through August 31, 2027, for comprehensive oncology diagnostic testing with CLIA and CAP accreditation requirements. Award volume has grown from 10 in 2022 to a high of 14 in 2024, though it declined to 7 in 2026 to date; seven awards totaling $5 million combined potential value reach ultimate completion inside the next twenty-four months, exposing the vendor to recompete activity.

Neogenomics' vehicle footprint sits on single-award indefinite delivery contracts and blanket purchase agreements with federal healthcare networks. The largest parent vehicles include an indefinite-delivery contract with VA VISN 17 (36C24118D0059, $16 million ceiling through December 31, 2027, with seven task orders totaling $3.2 million), a BPA with VA VISN 1 for FISH testing (3.076 million, April 1, 2024 through March 31, 2029), a $6.064 million IDC with VA VISN 21 for anatomic pathology (through April 25, 2026, now succeeded by a new $5 million IDC awarded April 26, 2026, extending through April 25, 2031), a BPA with the Indian Health Service for diagnostic reference laboratory testing ($2.125 million, awarded June 1, 2026, through May 31, 2031), and a $513,470 BPA with Air Mobility Command for anatomic pathology services (now expired as of January 31, 2024). Recent representative delivery orders include a $2,787,350 order from VA VISN 17 for specialized reference laboratory testing (completion December 31, 2026), a $643,694 order from VA VISN 21 for reference lab testing supporting the Chicagoland Health Care System in Fresno, California (completion April 25, 2027), and a $330,832 BPA call from the Indian Health Service for diagnostic reference laboratory testing at Phoenix Indian Medical Center (extended through June 19, 2026).

Place of performance spans Neogenomics' primary laboratory facilities at Fort Myers and Miromar Lakes, Florida, with subordinate operations at West Roxbury, Massachusetts (VISN 1 FISH testing), Fresno, California (VISN 21 pathology services), and Phoenix, Arizona (Indian Health Service testing). The NAICS footprint is heavily concentrated in Medical Laboratories (68 awards) and Testing Laboratories and Services (35 awards); the PSC code portfolio reflects Reference Laboratory Testing (103 awards), the dominant service category across the vendor's federal work.

Service Contract Inventory captures $3.2 million in SCI-reportable invoiced revenue across FY2023 and FY2024 (no FY2022 SCI activity), with FY2024 invoicing at $1.8 million across 1.4 FTEs and FY2023 at $1.4 million across 0.5 FTEs. Government-paid hourly rates on SCI-reportable prime contracts run a median of $950.44 per hour, with the 10th percentile at $589.84 per hour and the 90th percentile at $2,269.59 per hour, reflecting a mix of technical and professional laboratory staff. Neogenomics does not use subcontractors on its federal service contracts; 100% of delivery is performed by the vendor's own workforce, making it a self-contained laboratory services provider rather than a teaming or staffing intermediary. SCI figures represent a narrow slice of the vendor's federal revenue, capturing only service contracts above $150,000; the vendor's total federal work spans purchase orders, BPA calls, and IDC task orders across the full $70.3 million combined potential value, and does not reflect total enterprise revenue or non-federal operations.